10 Companies Reflect Market Decline

3. UnitedHealth Group Inc. (NYSE:UNH)

UnitedHealth Group (UNH) dropped its share prices by 6.04 percent on Thursday to end at $510.59 apiece following twin news of worse-than-expected revenues and that it was overcharging patients by more than 1,000 percent for key life-saving drugs.

Earlier this week, UnitedHealth said revenues settled at $100.81 billion during the fourth quarter of the year, below estimates of $101.76 billion as the company was hit by premiums that were lower than expected.

Net earnings, on the other hand, ended above expectations at $6.81 per share versus analyst expectations of $6.72 apiece.

The company kept its 2025 adjusted net earnings forecast of $29.50 to $30 a share the same.

Meanwhile, the Federal Trade Commission announced on Wednesday that UnitedHealth was found overcharging life-saving drugs by over 1,000 percent. According to the report, UnitedHealth’s OptumRx, along with Cigna’s Express Scripts and CVS Caremark Rx, were able to collectively pocket $7.3 billion in added revenue above cost during the five-year period of the study through 2022.